Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Har...
Elekta AB (publ) reported revenue of 16.72 billion SEK for fiscal year 2026, down 7.2% from fiscal year 2025, and net income of -519.00 million SEK. In Q1 2027 (the quarter ended July 31, 2026) revenue was 3.54 billion SEK, down 3.0% from a year before.
Figures from company filings; latest fiscal year ended April 30, 2026.
No profile data available.